White Papers | Pfizer CentreOne

Gene and cell therapy analytical and development methods: A path to success

Process development and analytical development are integral parts of gene therapy manufacturing. This whitepaper explores the analytical and development approaches needed to create a path to success in the clinic and beyond.

Considerations for Migrating a Drug Product Presentation from Vial to Pre-Filled Syringe

This whitepaper outlines the benefits of PFS transfer, the differences between glass and PFS devices, and the key engineering processes required to successfully carry out this process.

Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms

In this white paper Pfizer CentreOne examines what developers and their manufacturing partners need to know about its unique regulatory challenges and how to navigate HPOSD’s complex manufacturing environment successfully.

Placing Drug Strategies on a Solid Foundation for Success

Our whitepaper explores current market dynamics and the latest drug development trends driving these strategic outsourcing decisions.

How successful CDMO collaboration sets the foundation for sterile injectable product success

Pfizer CentreOne’s sterile injectables experts discuss how a small or medium sized biotech or pharma company can benefit from the experience and assistance provided by a CDMO for their sterile injectable project.

Liposomal and Nanoparticle Technology at Pfizer Melbourne

Medical science is continuously searching for better ways to administer drugs into the body and to maximise the therapeutic effectiveness of the drugs given.

Small Molecule APIs: Aligning Drug Strategy with Partnering Strategy

Development of novel small molecule active pharmaceutical ingredients (APIs) is increasingly turned over to outsourced partners who have become the primary drivers of the product’s overall development and go-to-market strategy.

Integrating Your Drug Strategy Within a Solid Foundation for Success

Demand for drugs and therapeutics is growing thanks to the globalization of pharmaceutical-based medicine.

Insights & Resources